Multispectral Light Therapy for Electron Transport Chain Complexes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current light therapy methods primarily target cytochrome c oxidase or Complex IV with red or near-infrared light, failing to effectively increase the activity and functioning ability of other electron transport chain complexes, which is crucial for optimal oxidative phosphorylation and mitochondrial function.
Innovation Solution
Applying light at specific wavelengths (violet-blue for Complexes I and II, green for Complex III, and red for Complex IV) to target each complex at its peak absorption, improving oxidative phosphorylation and mitochondrial function, either simultaneously or non-simultaneously, using a single device or multiple devices emitting subsets of wavelengths.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If light therapy targets only cytochrome c oxidase or Complex IV with red or near-infrared light, then Complex IV activity is improved, but other electron transport chain complexes (I, II, III) are not effectively stimulated
Solution Approach 1:
The patent divides the light therapy approach into separate wavelength segments, each targeting specific electron transport chain complexes. Violet-blue light (400-490 nm) targets Complexes I and II, green light (495-570 nm) targets Complex III, and red light (620-700 nm) targets Complex IV. This segmentation allows each complex to be stimulated at its peak absorption wavelength, resolving the contradiction by making the therapy versatile across all complexes while maintaining reliable stimulation of each individual complex.
Solution Approach 2:
The patent applies different light wavelengths with specific qualities to different molecular targets within the electron transport chain. Each complex has its own optimal absorption characteristics, and the therapy tailors the light quality (wavelength) to match each complex's local absorption properties. This local quality approach ensures that each complex receives the specific type of light energy it needs for optimal stimulation.
2Adaptability or versatility
If multiple wavelengths are applied simultaneously or non-simultaneously using a single device or multiple devices, then comprehensive coverage of all complexes is achieved, but device complexity increases
Solution Approach 1:
The patent describes a light therapy device capable of emitting multiple wavelengths (violet-blue, green, and red) either simultaneously or sequentially. This multi-functional device can target all electron transport chain complexes using a single apparatus, reducing the need for multiple separate devices while maintaining comprehensive coverage. The device's ability to switch between or combine wavelengths provides universal applicability across all complexes.
Solution Approach 2:
The patent combines multiple light wavelength sources into a unified therapy approach that can be delivered through a single device or coordinated multiple devices. By merging the functionality of separate wavelength emitters into one system, the patent achieves comprehensive coverage of all electron transport chain complexes while minimizing device complexity through integration.
3Productivity
If light intensity is increased to enhance mitochondrial function, then oxidative phosphorylation is improved, but tissue damage or temperature changes may occur
Solution Approach 1:
The patent applies low-level light therapy at intensities that are sufficient to stimulate mitochondrial function and enhance oxidative phosphorylation without exceeding the threshold that would cause tissue damage or excessive temperature changes. This partial action approach uses just enough light energy to achieve the desired metabolic effect while avoiding harmful over-stimulation.
Solution Approach 2:
The patent employs periodic or pulsed light delivery patterns that allow tissue recovery between exposure cycles. By delivering light energy in periodic bursts rather than continuous high-intensity exposure, the therapy enhances oxidative phosphorylation through repeated stimulation while preventing cumulative tissue damage and excessive heat buildup.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances oxidative phosphorylation and mitochondrial function by increasing the activity of each electron transport chain complex, leading to improved cellular metabolism and potential therapeutic benefits for various conditions without causing tissue damage or temperature changes.
Implementation Method 1
Each complex of the electron transport chain has different wavelengths at which there is peak absorption of the light. Methods described herein apply light at defined ranges of wavelengths to a patient's skin, targeting each complex of the electron transport chain at its peak absorption
Data Source
AI summary
Each electron transport chain complex has different wavelengths at which there is peak absorption of the light. Methods described herein apply light at defined ranges of wavelengths to a patient's skin, targeting each complex of the electron transport chain at its peak absorption, to increase the activity of the respective complex. This results in improved oxidative phosphorylation and mitochondrial function in the area treated. Complexes I and II are treated with violet-blue (400-490 nm) light. Complex I is treated with green (495-570 nm) light. Complex IV is treated with red (620-700 nm) light. To achieve optimal oxidative phosphorylation all three colors are applied to the treatment area, simultaneously or non-simultaneously. The light energy can be applied using a single device that can emit all three wavelengths, or multiple devices that emit a subset of the desired wavelengths.